Related Articles
Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells
Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs
Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells Retraction in /10.3892/ol.2023.13938
MECHANISMS OF DEREGULATED HER2/NEU EXPRESSION IN BREAST-CANCER CELL-LINES